drugset / Trial / NCT00644280

Ranibizumab in Preventing Failure of Ahmed Valve Glaucoma Surgery

NCT00644280

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine whether ranibizumab therapy before and after tube insertion for glaucoma surgeries can maintain the patency of the tube and prevent scar formation, and increase the chances for a successful procedure compared to observation.

Timeline

Start
2008-04
Primary completion
2010-12
Completion
2011-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ranibizumab Monoclonal antibody 0.5 mg Intravitreal

Indications